About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Trp63tm3.1Brd
targeted mutation 3.1, Allan Bradley
MGI:2385473
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Trp63tm3.1Brd/Trp63tm3.1Brd involves: 129S7/SvEvBrd MGI:3798053
cn2
 		Tg(KRT5-cre/PGR)1Der/0
Trp63tm2Brd/Trp63tm3.1Brd 		involves: 129S7/SvEvBrd * FVB * ICR MGI:3798054


Genotype
MGI:3798053
hm1
Allelic
Composition		 Trp63tm3.1Brd/Trp63tm3.1Brd
Genetic
Background		 involves: 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp63tm3.1Brd mutation (0 available); any Trp63 mutation (60 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
cellular
decreased cell proliferation ( J:100483 )
• when keratinocytes are treated with an adenovirus cre, cellular proliferation is decreased
early cellular replicative senescence ( J:100483 )
• when keratinocytes are treated with an adenovirus cre, cells exhibit premature senescence




Genotype
MGI:3798054
cn2
Allelic
Composition		 Tg(KRT5-cre/PGR)1Der/0
Trp63tm2Brd/Trp63tm3.1Brd
Genetic
Background		 involves: 129S7/SvEvBrd * FVB * ICR
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(KRT5-cre/PGR)1Der mutation (0 available)
Trp63tm2Brd mutation (1 available); any Trp63 mutation (60 available)
Trp63tm3.1Brd mutation (0 available); any Trp63 mutation (60 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
cellular
early cellular replicative senescence ( J:100483 )
• following treatment with mifepristonein in utero, mice exhibit an increase in cellular senescence

craniofacial
abnormal craniofacial morphology ( J:100483 )
• at E17.5 following treatment with mifepristonein in utero

limbs/digits/tail
abnormal limb morphology ( J:100483 )
• at E17.5 following treatment with mifepristonein in utero

growth/size/body
weight loss ( J:100483 )
• following treatment with mifepristonein at 8 months of age

skeleton
lordokyphosis ( J:100483 )
• following treatment with mifepristonein at 8 months of age, mice exhibit lordokyphosis that increases with severity as mice age

integument
alopecia ( J:100483 )
• following treatment with mifepristonein at 8 months of age, mice exhibit severe alopecia
abnormal skin morphology ( J:100483 )
• at E17.5 following treatment with mifepristonein in utero or at 8 months of age
abnormal epidermal layer morphology ( J:100483 )
• following treatment with mifepristonein utero, mice exhibit stratified epidermal layer and arrested epidermal morphogenesis




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory